claim
Immunotherapy treatments, including immune checkpoint inhibitors and CAR T-cell therapies, are associated with adverse events ranging from mild skin reactions and gastrointestinal symptoms to severe immune-related toxicities such as colitis, hepatitis, pneumonitis, and endocrinopathies.

Authors

Sources

Referenced by nodes (2)